Coelomic Fluid of Eisenia fetida Ameliorates Cetuximab to Reduce K-Ras and Vimentin Expression through Promoting RUNX3 in an AOM/DSS-Induced Colitis Associated Colon Cancer

Figure 5

E-Cadherin and β-catenin expressions were reduced by CFEF-cetuximab in colon tissue. The expression of E-cadherin and β-catenin after therapies with cetuximab and various concentrations of CFEF (30, 60, and 120 mg/g BW) were analyzed using immunofluorescence. (a) Representative images of E-cadherin expression showed slightly higher on the combination therapy group. (b) The percentage of E-cadherin expression increased on the combination therapy groups compared with cetuximab single group. (c) Representative images of β-catenin expression showed higher on the combination therapy group. (d) The percentage of β-catenin expression increased on combination therapy groups compared with cetuximab single group. Results shown are mean ± SD, with n = 6 replicates in each group. , .

(a)

(b)

(c)

(d)